Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy
Rm. Knott et al., Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy, METABOLISM, 48(9), 1999, pp. 1172-1178
In the present study, we examined the effect of glucose concentration on th
e expression of vascular endothelial growth factor (VEGF), basic fibroblast
growth factor (bFGF), and transforming growth factor-beta (TGF-beta) mRNA
using reverse transcriptase-polymerase chain reaction (RT-PCR) in normal he
althy leukocytes in vitro and in leukocytes from patients with type 1 diabe
tes mellitus. In vitro, the level of TGF-beta mRNA was altered in response
to the glucose concentration (maximum at 10 mmol/L), while bFGF mRNA remain
ed relatively constant and VEGF mRNA varied with no clear correlation with
the glucose concentration. Leukocytes from type 1 patients showed no differ
ence in bFGF or TGF-beta mRNA levels compared with age-matched healthy cont
rols. However, VEGF mRNA was significantly lower in type 1 patients compare
d with controls (P < .05). When the patients were subtyped according to the
severity of retinopathy, the level of TGF-beta mRNA was elevated selective
ly in patients with evidence of active new retinal vessels (P < .01) and VE
GF(121) mRNA was reduced in patients with mild to moderate retinopathy. Thu
s, leukocyte growth factor mRNAs respond to acute changes in the glucose co
ncentration in vitro, and are differentially expressed in type 1 diabetic p
atients during the course of the disease. Copyright(C) 1999 by W.B. Saunder
s Company.